论文部分内容阅读
应用SHG—1型生物发光测量仪,对30例卵巢恶性肿瘤、10例良性肿瘤和30例健康女性进行血清自发化学发光和诱发化学发光测定。结果发现,卵巢恶性肿瘤患者血清自发化学发光和诱发化学发光较良性肿瘤患者和正常对照组均明显升高。表明血清超弱发光的增强可以作为卵巢恶性肿瘤诊断的参考指标。
The spontaneous chemiluminescence and chemiluminescence determination of serum in 30 cases of ovarian cancer, 10 cases of benign tumor and 30 healthy women were performed by SHG-1 bioluminescence measuring instrument. The results showed that patients with ovarian cancer spontaneous chemiluminescence chemiluminescence and benign tumor patients and normal control group were significantly higher. That ultra-weak serum light can enhance the diagnosis of ovarian cancer as a reference index.